Clozapine may partially compensate for task-related brain perfusion abnormalities in risperidone-resistant schizophrenia patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 4, 2008, Pages 948-954

  Molina, V ^a   Tamayo, P ^a   Montes, C ^a   De Luxan A ^b   Martin, C ^a   Rivas, N ^a   Sancho, C ^c   Dominguez Gil A ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Brain perfusion; Clozapine; Risperidone; Schizophrenia

Indexed keywords

CLOZAPINE; CYCLOHEXANE; HALOPERIDOL; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; RISPERIDONE;

ARTICLE; BRAIN PERFUSION; BRAIN STEM; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; DRUG EFFECT; FEMALE; HIPPOCAMPUS; HUMAN; INSULA; MALE; MENTAL PERFORMANCE; PREFRONTAL CORTEX; SCHIZOPHRENIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT RESPONSE;

EID: 42949126347     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.12.028     Document Type: Article

References (36)

1. Agid O. Kapur S. Arenovich T. Zipursky R.B. Delayed-onset hypothesis of antipsychotic action: a hypothesis tested and rejected Arch Gen Psychiatry 60 2003 1228 1235
2. Alvarez J.A. Emory E. Executive function and the frontal lobes: a meta-analytic review Neuropsychol Rev 16 2006 17 42
3. Buchsbaum M.S. Someya T. Teng C.Y. Abel L. Chin S. Najafi A. PET and MRI of the thalamus in never-medicated patients with schizophrenia Am J Psychiatry 153 1996 191 199
4. Callicott J.H. Bertolino A. Mattay V.S. Langheim F.J. Duyn J. Coppola R. Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited Cereb Cortex 10 2000 1078 1092
5. Carter C.S. Mintun M. Nichols T. Cohen J.D. Anterior cingulate gyrus dysfunction and selective attention deficits in schizophrenia: [15O]H2O PET study during single- trial Stroop task performance [see comments] Am J Psychiatry 154 1997 1670 1675
6. Cohen R.M. Nordahl T.E. Semple W.E. Andreason P. Litman R.E. Pickar D. The brain metabolic patterns of clozapine- and fluphenazine-treated patients with schizophrenia during a continuous performance task Arch Gen Psychiatry 54 1997 481 486
7. Conley R.R. Kelly D.L. Beason-Held L.L. Holcomb H.H. Richardson C.M. The effects of clozapine and high-dose olanzapine on brain function in treatment-resistant schizophrenia: a case study J Psychopharmacol 18 2004 429 431
8. Dolan R.J. Fletcher P. Frith C.D. Friston K.J. Frackowiak R.S. Grasby P.M. Dopaminergic modulation of impaired cognitive activation in the anterior cingulate cortex in schizophrenia Nature 378 1995 180 182
9. Frackowiak R.S.J. Friston K.J. Frith C.D. Dolan R.J. Mazziotta J.C. Human brain function 1997 Academic Press San Diego
10. Goethals I. Audenaert K. Jacobs F. Lannoo E. Van de Wiele C. Ham H. Cognitive neuroactivation using SPECT and the Stroop Colored Word Test in patients with diffuse brain injury J Neurotrauma 21 2004 1059 1069
11. Goldberg T.E. Weinberger D.R. The effects of clozapine on neurocognition: an overview J Clin Psychiatry 55 Suppl B 1994 88 90
12. Hollingshead A. Frederick R. Social stratification and psychiatric disorders Am Soc Rev 18 1953 163 189
13. Kay S.R. Fiszbein A. Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 13 1987 261 276
14. Lahti A.C. Holcomb H.H. Weiler M.A. Medoff D.R. Frey K.N. Hardin M. Clozapine but not haloperidol re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex Neuropsychopharmacology 1 2003 1
15. Lahti A.C. Holcomb H.H. Weiler M.A. Medoff D.R. Tamminga C.A. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol Biol Psychiatry 53 2003 601 608
16. Laruelle M. Abi-Dargham A. Gil R. Kegeles L. Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases Biol Psychiatry 46 1999 56 72
17. Leung H.C. Skudlarski P. Gatenby J.C. Peterson B.S. Gore J.C. An event-related functional MRI study of the Stroop color word interference task Cereb Cortex 10 2000 552 560
18. Liddle P.F. Friston K.J. Frith C.D. Hirsch S.R. Jones T. Frackowiak R.S. Patterns of cerebral blood flow in schizophrenia Br J Psychiatry 160 1992 179 186
19. Liddle P.F. Lane C.J. Ngan E.T. Immediate effects of risperidone on cortico–striato–thalamic loops and the hippocampus [in process citation] Br J Psychiatry 177 2000 402 407
20. Manoach D.S. Press D.Z. Thangaraj V. Searl M.M. Goff D.C. Halpern E. Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI Biol Psychiatry 45 1999 1128 1137
21. Mead L.A. Mayer A.R. Bobholz J.A. Woodley S.J. Cunningham J.M. Hammeke T.A. Neural basis of the Stroop interference task: response competition or selective attention? J Int Neuropsychol Soc 8 2002 735 742
22. Miller D.D. Andreasen N.C. O'Leary D.S. Watkins G.L. Boles Ponto L.L. Hichwa R.D. Comparison of the effects of risperidone and haloperidol on regional cerebral blood flow in schizophrenia Biol Psychiatry 49 2001 704 715
23. Min S.K. An S.K. Jon D.I. Lee J.D. Positive and negative symptoms and regional cerebral perfusion in antipsychotic-naive schizophrenic patients: a high-resolution SPECT study Psychiatry Res 90 1999 159 168
24. Moghaddam B. Bunney B.S. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study J Neurochem 54 1990 1755 1760
25. Molina V. Gispert J.D. Reig S. Sanz J. Pascau J. Santos A. Cerebral metabolic changes induced by clozapine in schizophrenia Psychopharmacology 178 2005 17 26
26. Molina V. Gispert J.D. Reig S. Sanz J. Pascau J. Santos A. Cerebral metabolism and risperidone treatment in schizophrenia Schizophrenia Res 60 2003 1 7
27. Molina V. Sarramea F. Sanz J. Benito C. Palomo T. Prefrontal atrophy in first episodes of schizophrenia associated with limbic hyperactivity J Psychiatric Res 39 2005 117 127
28. Potkin S.G. Basile V.S. Jin Y. Masellis M. Badri F. Keator D. D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine Mol Psychiatry 8 2003 109 113
29. Sabri O. Erkwoh R. Schreckenberger M. Cremerius U. Schulz G. Dickmann C. Regional cerebral blood flow and negative/positive symptoms in 24 drug-naive schizophrenics J Nucl Med 38 1997 181 188
30. Schall U. Catts S.V. Chaturvedi S. Liebert B. Redenbach J. Karayanidis F. The effect of clozapine therapy on frontal lobe dysfunction in schizophrenia: neuropsychology and event-related potential measures Int J Neuropsychopharmcol 1 1998 19 29
31. Sesack S.R. Carr D.B. Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia Physiol Behav 77 2002 513 517
32. Siegel B.V. Jr. Buchsbaum M.S. Bunney W.E. Jr. Gottschalk L.A. Haier R.J. Lohr J.B. Cortical–striatal–thalamic circuits and brain glucose metabolic activity in 70 unmedicated male schizophrenic patients Am J Psychiatry 150 1993 1325 1336
33. Talairach J. Tournoux P. Co-planar stereotaxic atlas of the human brain 1988 New York Thieme Medical
34. Taylor S.F. Kornblum S. Lauber E.J. Minoshima S. Koeppe R.A. Isolation of specific interference processing in the Stroop task: PET activation studies Neuroimage 6 1997 81 92
35. Weiss E.M. Siedentopf C. Golaszewski S. Mottaghy F.M. Hofer A. Kremser C. Brain activation patterns during a selective attention test—a functional MRI study in healthy volunteers and unmedicated patients during an acute episode of schizophrenia Psychiatry Res 154 2007 31 40
36. Winterer G. Coppola R. Goldberg T.E. Egan M.F. Jones D.W. Sanchez C.E. Prefrontal broadband noise, working memory, and genetic risk for schizophrenia Am J Psychiatry 161 2004 490 500